TCL Archive HEW Approves New Cancer Clinical Education Grants, Without Trainee Stipends ; $4 Million Available In ’75 April 26, 1974
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive In NEJM Letter, Henschke Acknowledges Error In 2006 I-ELCAP Paper; Critics Call For Audit. August 8, 2008
